Biogen Inc. (BIIB)

Healthcare · Drug Manufacturers General · NASDAQ

S&P 500

Biogen Inc. (BIIB) is a Healthcare company in the Drug Manufacturers General industry. It has a market capitalization of $33.30B, a trailing price-to-earnings ratio of 16.1 and a free-cash-flow yield of 5.9%. Over the most recent reported fiscal year, revenue grew 2.2% and free cash flow per share fell 22.4%.

Market cap	$33.30B
Trailing P/E	16.1
FCF yield	5.9%
Revenue growth (YoY)	+2.2%
EPS growth (YoY)	-7.2%
FCF/share growth (YoY)	-22.4%
Exchange	NASDAQ
Sector	Healthcare
Industry	Drug Manufacturers General

Explore live BIIB data on Nama Insights →

Recent Congressional trades

Biogen Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Alan Armstrong	Senate	Buy	$1,001 - $15,000	Jul 21, 2026
Alan Armstrong	Senate	Buy	$1,001 - $15,000	Jul 21, 2026
Maria Elvira Salazar	House	Sell	$15,001 - $50,000	Jul 7, 2026
Maria Elvira Salazar	House	Buy	$1,001 - $15,000	Jun 8, 2026
Maria Elvira Salazar	House	Buy	$50,001 - $100,000	Jun 8, 2026